Phenotypic rescue of mice with Dravet syndrome, the more severe form of epilepsy due to SCN1A variants with mostly LoF variants, has led to development of several gene therapy approaches including oligonucleotides and viral vectors [39]. The gene discussed is SCN1A; the disease is encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.